OROPHARYNGEAL CANCER STAGE UNSPECIFIED

OROPHARYNGEAL CANCER STAGE UNSPECIFIED was reported 37 times

OROPHARYNGEAL CANCER STAGE UNSPECIFIED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Blood Viscosity Reducer [EPC] 1 0.0002
1 Vasopressin V2 Receptor Antagonist [EPC] 1 0.0001
2 Epidermal Growth Factor Receptor Antagonist [EPC] 2 0.0000
3 Sympathomimetic-like Agent [EPC] 1 0.0000
4 Aminoglycoside Antibacterial [EPC] 1 0.0000
5 Platinum-based Drug [EPC] 4 0.0000
6 Tetracycline-class Drug [EPC] 1 0.0000
7 Folate Analog Metabolic Inhibitor [EPC] 5 0.0000
8 Tumor Necrosis Factor Blocker [EPC] 10 0.0000
9 Thiazide Diuretic [EPC] 2 0.0000
10 Parathyroid Hormone Analog [EPC] 1 0.0000
11 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
12 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
13 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
14 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
15 Phosphodiesterase 5 Inhibitor [EPC] 1 0.0000
16 Loop Diuretic [EPC] 3 0.0000
17 Azole Antifungal [EPC] 1 0.0000
18 Microtubule Inhibitor [EPC] 1 0.0000
19 Estrogen [EPC] 1 0.0000
20 Proton Pump Inhibitor [EPC] 3 0.0000
21 Mood Stabilizer [EPC] 1 0.0000
22 Anti-epileptic Agent [EPC] 1 0.0000
23 Atypical Antipsychotic [EPC] 2 0.0000
24 Benzodiazepine [EPC] 3 0.0000
25 Opioid Agonist [EPC] 1 0.0000
26 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
27 Platelet Aggregation Inhibitor [EPC] 2 0.0000
28 Osmotic Laxative [EPC] 1 0.0000
29 Vitamin D [EPC] 1 0.0000
30 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
31 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
32 Vitamin B12 [EPC] 1 0.0000
33 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
34 Vitamin C [EPC] 1 0.0000
35 Corticosteroid [EPC] 2 0.0000
36 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000